Recombinant Cnpase antibody
Quick Overview for Recombinant Cnpase antibody (ABIN7090703)
Target
See all Cnpase (CNP) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- CNPase Recombinant Antibody
-
Cross-Reactivity
- Human, Rat
-
Purification
- Purified by Protein G.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CNPase
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- WB(WB(1:500-5000)), IHC-P(IHC-P(1:100-500)), IHC-F(IHC-F(1:100-500)), IF(IHC-P)(IF(IHC-P)(1:100-500)), IF(ICC)(IF(ICC)(1:50-200))
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 0.01M TBS ( pH 7.4), 1 % BSA, 0.02 % Proclin 300, and 50 % Glycerol
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- Cnpase (CNP) (2',3'-Cyclic Nucleotide 3' phosphodiesterase (CNP))
-
Alternative Name
- CNPase
-
Background
-
Synonyms: 2',3'-cyclic-nucleotide 3'-phosphodiesterase, CNPase, Cnp, Cnp-1, Cnp1, 2'', 2'3' cyclic nucleotide 3' phosphodiesterase, 2'3'-cyclic-nucleotide 3'-phosphodiesterase, 3''-cyclic-nucleotide 3''-phosphodiesterase, CN37_HUMAN, CNP 1, CNP, CNP1.
Background: Predicted to enable 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity. Involved in substantia nigra development. Located in several cellular components, including extracellular space, microtubule, and plasma membrane. Implicated in hypomyelinating leukodystrophy 20, multiple sclerosis, and schizophrenia. Biomarker of alcoholic liver cirrhosis, multiple sclerosis, and restless legs syndrome. [provided by Alliance of Genome Resources, Nov 2021]
-
Gene ID
- 1267
-
UniProt
- P09543
Target
-